Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000549455 | SCV000646192 | likely benign | Multiple endocrine neoplasia type 4 | 2024-01-25 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000565024 | SCV000673216 | likely benign | Hereditary cancer-predisposing syndrome | 2017-06-13 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Sema4, |
RCV000565024 | SCV002535470 | likely benign | Hereditary cancer-predisposing syndrome | 2021-06-30 | criteria provided, single submitter | curation | |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV003478159 | SCV004220742 | likely benign | not provided | 2023-07-28 | criteria provided, single submitter | clinical testing |